<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00808340</url>
  </required_header>
  <id_info>
    <org_study_id>CR-1485FA</org_study_id>
    <nct_id>NCT00808340</nct_id>
  </id_info>
  <brief_title>Comparison of Three Soft Bifocal Contact Lenses</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <brief_summary>
    <textblock>
      The primary purpose of the study is to compare the performance of three soft bifocal contact
      lenses in terms of the vision provided by the lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2008</start_date>
  <completion_date type="Actual">December 1, 2008</completion_date>
  <primary_completion_date type="Actual">December 1, 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance Bright Illumination Binocular Visual Performance Reported as Visual Acuity</measure>
    <time_frame>5 minutes after insertion</time_frame>
    <description>Tested with both eyes together in bright lighting, reading charts distant to the subject. This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution. Ideal is 0.0 and represents 20/20 Snellen acuity. logMAR values &gt; 0.00 indicate vision poorer than the ideal and values &lt;0.00 indicate vision greater than the ideal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Near Bright Illumination Binocular Visual Performance Reported as Visual Acuity</measure>
    <time_frame>5 minutes after insertion</time_frame>
    <description>Tested with both eyes together in bright lighting reading charts near to the subject. This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution. Ideal is 0.0 and represents 20/20 Snellen acuity. logMAR values &gt; 0.00 indicate vision poorer than the ideal and values &lt;0.00 indicate vision greater than the ideal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Type of Corneal Staining</measure>
    <time_frame>after 1 week of lens wear, for each lens type</time_frame>
    <description>Investigator rated type of corneal staining as either 0=none, 1=micropunctate, 2=macropunctate, 3=coalesced, or 4=patch(&gt; or = to mm).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Subjective Vision</measure>
    <time_frame>after 1 week of lens wear, for each lens type</time_frame>
    <description>Subject rated the overall quality of vision with the study contact lenses. 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>senofilA test/senofilA prod/balafilconA</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects wear 3 multifocal contact lenses: senofilcon A test worn first, senofilcon A production worn second, and balafilcon A worn third.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>senofilcon A test/balafilcon A/senofilcon A prod</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects wear 3 multifocal contact lenses: senofilcon A test worn first, balafilcon A worn second, and senofilcon A production worn third.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>senofilcon A prod/senofilcon A test/balafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects wear 3 multifocal contact lenses: senofilcon A production worn first, senofilcon A test worn second, and balafilcon A worn third.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>senofilcon A prod/ balifilcon A/ senofilcon A test</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects wear 3 multifocal contact lenses: senofilcon A production worn first, balafilcon A worn second, and senofilcon A test worn third.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>balafilcon A/senofilcon A test/senofilcon A prod</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects wear 3 multifocal contact lenses: balafilcon A worn first, senofilcon A test worn second, and senofilcon A production worn third.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>balafilcon A/senofilcon A prod/senofilcon A test</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects wear 3 multifocal contact lenses: balafilcon A worn first, senofilcon A production worn second, senofilcon A test worn third.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>balafilcon A</intervention_name>
    <description>multifocal contact lens</description>
    <arm_group_label>senofilA test/senofilA prod/balafilconA</arm_group_label>
    <arm_group_label>senofilcon A test/balafilcon A/senofilcon A prod</arm_group_label>
    <arm_group_label>senofilcon A prod/senofilcon A test/balafilcon A</arm_group_label>
    <arm_group_label>senofilcon A prod/ balifilcon A/ senofilcon A test</arm_group_label>
    <arm_group_label>balafilcon A/senofilcon A test/senofilcon A prod</arm_group_label>
    <arm_group_label>balafilcon A/senofilcon A prod/senofilcon A test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon A production</intervention_name>
    <description>multifocal contact lens</description>
    <arm_group_label>senofilA test/senofilA prod/balafilconA</arm_group_label>
    <arm_group_label>senofilcon A test/balafilcon A/senofilcon A prod</arm_group_label>
    <arm_group_label>senofilcon A prod/senofilcon A test/balafilcon A</arm_group_label>
    <arm_group_label>senofilcon A prod/ balifilcon A/ senofilcon A test</arm_group_label>
    <arm_group_label>balafilcon A/senofilcon A test/senofilcon A prod</arm_group_label>
    <arm_group_label>balafilcon A/senofilcon A prod/senofilcon A test</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon A test</intervention_name>
    <description>multifocal contact lens</description>
    <arm_group_label>senofilA test/senofilA prod/balafilconA</arm_group_label>
    <arm_group_label>senofilcon A test/balafilcon A/senofilcon A prod</arm_group_label>
    <arm_group_label>senofilcon A prod/senofilcon A test/balafilcon A</arm_group_label>
    <arm_group_label>senofilcon A prod/ balifilcon A/ senofilcon A test</arm_group_label>
    <arm_group_label>balafilcon A/senofilcon A test/senofilcon A prod</arm_group_label>
    <arm_group_label>balafilcon A/senofilcon A prod/senofilcon A test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject must between 35 and 70 years of age.

          -  The subject must respond positively to at least one symptom on the &quot;Presbyopic
             Symptoms Questionnaire&quot; or be already wearing presbyopic contact lens correction (
             e.g. reading spectacles over contact lenses, multifocal or monovision contact lenses
             etc.).

          -  The subject's spherical equivalent distance refraction must be in the range of -1.00
             to -6.00 in each eye.

          -  Refractive cylinder must be less than or equal to -0.75 D in each eye.

          -  The subject must have an add power of +0.75D to +2.50D in each eye.

          -  The subject must have best corrected visual acuity of 20/20-3 or better in each eye.

          -  The subject's must have at least 20/30-distance vision with the study contact lenses.

          -  The subject must agree that they are comfortable with their vision prior to being
             dispensed the study lenses.

          -  The subject must be an adapted soft contact lens wearer in both eyes.

          -  The subject must appear able and willing to adhere to the instructions set forth in
             this clinical protocol.

          -  The subject must read and sign the STATEMENT OF INFORMED CONSENT and be provided a
             copy of the form.

        Exclusion Criteria:

          -  Ocular or systemic allergies or disease that may interfere with contact lens wear.

          -  Systemic disease, autoimmune disease or use of medication, which may interfere with
             contact lens wear.

          -  Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal
             staining or any other abnormality of the cornea, which may contraindicate contact lens
             wear.

          -  Clinically significant (grade 3 or 4) tarsal abnormalities that might interfere with
             contact lens wear.

          -  Any ocular infection.

          -  Any corneal distortion resulting from previous hard or rigid gas permeable contact
             lens wear.

          -  Pregnancy or lactation

          -  Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious
             immunosuppressive disease (e.g., HIV).

          -  History of diabetes. History of binocular vision abnormality or strabismus.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2008</study_first_submitted>
  <study_first_submitted_qc>December 12, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 15, 2008</study_first_posted>
  <results_first_submitted>July 30, 2010</results_first_submitted>
  <results_first_submitted_qc>July 30, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 26, 2010</results_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Senofilcon A Test/Senofilcon A Prod/Balafilcon A</title>
          <description>Subjects wear 3 multifocal contact lenses: senofilcon A test worn first, senofilcon A production worn second, and balafilcon A worn third.</description>
        </group>
        <group group_id="P2">
          <title>Senofilcon A Test/Balafilcon A/Senofilcon A Prod</title>
          <description>Subjects wear 3 multifocal contact lenses: senofilcon A test worn first, balafilcon A worn second, and senofilcon A production worn third.</description>
        </group>
        <group group_id="P3">
          <title>Senofilcon A Prod/Senofilcon A Test/Balafilcon A</title>
          <description>Subjects wear 3 multifocal contact lenses: senofilcon A prod worn first, senofilcon A test worn second, and balafilcon A worn third.</description>
        </group>
        <group group_id="P4">
          <title>Senofilcon A Prod/ Balifilcon A/ Senofilcon A Test</title>
          <description>Subjects wear 3 multifocal contact lenses: senofilcon A prod worn first, balafilcon A worn second, and senofilcon A test worn third.</description>
        </group>
        <group group_id="P5">
          <title>Balafilcon A/Senofilcon A Test/Senofilcon A Prod</title>
          <description>Subjects wear 3 multifocal contact lenses: balafilcon A worn first, senofilcon A test worn second, and senofilcon A production worn third.</description>
        </group>
        <group group_id="P6">
          <title>Balafilcon A/Senofilcon A Prod/Senofilcon A Test</title>
          <description>Subjects wear 3 multifocal contact lenses: balafilcon A worn first, senofilcon A producton worn second, senofilcon A test worn third.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Third Intervention</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="7"/>
                <participants group_id="P4" count="3"/>
                <participants group_id="P5" count="5"/>
                <participants group_id="P6" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Overall completed study population</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.5" spread="6.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Distance Bright Illumination Binocular Visual Performance Reported as Visual Acuity</title>
        <description>Tested with both eyes together in bright lighting, reading charts distant to the subject. This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution. Ideal is 0.0 and represents 20/20 Snellen acuity. logMAR values &gt; 0.00 indicate vision poorer than the ideal and values &lt;0.00 indicate vision greater than the ideal.</description>
        <time_frame>5 minutes after insertion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Test</title>
            <description>senofilcon A test represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A Prod</title>
            <description>senofilcon A prod represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
          <group group_id="O3">
            <title>Balafilcon A</title>
            <description>balafilcon A represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
        </group_list>
        <measure>
          <title>Distance Bright Illumination Binocular Visual Performance Reported as Visual Acuity</title>
          <description>Tested with both eyes together in bright lighting, reading charts distant to the subject. This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution. Ideal is 0.0 and represents 20/20 Snellen acuity. logMAR values &gt; 0.00 indicate vision poorer than the ideal and values &lt;0.00 indicate vision greater than the ideal.</description>
          <units>logMAR</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8191" spread="0.161"/>
                    <measurement group_id="O2" value="0.6942" spread="0.161"/>
                    <measurement group_id="O3" value="1.0635" spread="0.161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is that senofilcon A multifocal prod is non-inferior to senofilcon A multifocal test.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = -0.5.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.1249</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1464</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.4143</ci_lower_limit>
            <ci_upper_limit>0.1644</ci_upper_limit>
            <estimate_desc>Mean difference is calculated as senofilcon A multifocal prod minus senofilcon A multifocal test.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is that senofilcon A multifocal prod is non-inferior to balafilcon A multifocal.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = -0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.3693</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1464</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.6587</ci_lower_limit>
            <ci_upper_limit>-0.07996</ci_upper_limit>
            <estimate_desc>The mean difference was calculated as balafilcon A multifocal minus senofilcon A multifocal prod.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Near Bright Illumination Binocular Visual Performance Reported as Visual Acuity</title>
        <description>Tested with both eyes together in bright lighting reading charts near to the subject. This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution. Ideal is 0.0 and represents 20/20 Snellen acuity. logMAR values &gt; 0.00 indicate vision poorer than the ideal and values &lt;0.00 indicate vision greater than the ideal.</description>
        <time_frame>5 minutes after insertion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Test</title>
            <description>senofilcon A test represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A Prod</title>
            <description>senofilcon A prod represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
          <group group_id="O3">
            <title>Balafilcon A</title>
            <description>balafilcon A represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
        </group_list>
        <measure>
          <title>Near Bright Illumination Binocular Visual Performance Reported as Visual Acuity</title>
          <description>Tested with both eyes together in bright lighting reading charts near to the subject. This outcome is measured in logMAR units.LogMAR stands for the logarithm of the minimum angle of resolution. Ideal is 0.0 and represents 20/20 Snellen acuity. logMAR values &gt; 0.00 indicate vision poorer than the ideal and values &lt;0.00 indicate vision greater than the ideal.</description>
          <units>logMAR</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6735" spread="0.161"/>
                    <measurement group_id="O2" value="-0.6327" spread="0.161"/>
                    <measurement group_id="O3" value="-0.1719" spread="0.161"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is that senofilcon A multifocal prod is non-inferior to senofilcon A multifocal test.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = -0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.04083</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1464</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.2485</ci_lower_limit>
            <ci_upper_limit>0.3302</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as senofilcon A multifocal prod minus senofilcon A multifocal test.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is that senofilcon A multifocal prod is non-inferior to balafilcon A multifocal.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = -0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.4608</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1464</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.7502</ci_lower_limit>
            <ci_upper_limit>-0.1714</ci_upper_limit>
            <estimate_desc>The mean difference was calculated as senofilcon A multifocal prod minus balafilcon A multifocal.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Type of Corneal Staining</title>
        <description>Investigator rated type of corneal staining as either 0=none, 1=micropunctate, 2=macropunctate, 3=coalesced, or 4=patch(&gt; or = to mm).</description>
        <time_frame>after 1 week of lens wear, for each lens type</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Test</title>
            <description>senofilcon A test represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A Prod</title>
            <description>senofilcon A prod represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
          <group group_id="O3">
            <title>Balafilcon A</title>
            <description>balafilcon A represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
        </group_list>
        <measure>
          <title>Type of Corneal Staining</title>
          <description>Investigator rated type of corneal staining as either 0=none, 1=micropunctate, 2=macropunctate, 3=coalesced, or 4=patch(&gt; or = to mm).</description>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.1311" spread="0.07154"/>
                    <measurement group_id="O2" value="0.1017" spread="0.07154"/>
                    <measurement group_id="O3" value="0.1694" spread="0.07154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is senofilcon A multifocal prod is non-inferior to senofilcon A multifocal test.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = 0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.02941</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02656</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.08153</ci_lower_limit>
            <ci_upper_limit>0.02271</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as senofilcon A multifocal prod minus senofilcon A multifocal test.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is senofilcon A multifocal prod is non-inferior to balafilcon A multifocal.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = 0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.06765</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02656</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.1198</ci_lower_limit>
            <ci_upper_limit>-0.01553</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as senfilcon A multifocal prod minus balafilcon A multifocal.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overall Subjective Vision</title>
        <description>Subject rated the overall quality of vision with the study contact lenses. 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
        <time_frame>after 1 week of lens wear, for each lens type</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Test</title>
            <description>senofilcon A test represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A Prod</title>
            <description>senofilcon A prod represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
          <group group_id="O3">
            <title>Balafilcon A</title>
            <description>balafilcon A represents subjects that wore this lens in either the first, second, or third period.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Subjective Vision</title>
          <description>Subject rated the overall quality of vision with the study contact lenses. 5=excellent, 4=very good, 3=good, 2=fair, 1=poor.</description>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
                <count group_id="O3" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5373" spread="0.1681"/>
                    <measurement group_id="O2" value="3.207" spread="0.1681"/>
                    <measurement group_id="O3" value="3.4351" spread="0.1681"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hyposthesis is that senofilcon A multifocal prod is non-inferior to senofilcon A multifocal test.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = -0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.3304</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.2243</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.779</ci_lower_limit>
            <ci_upper_limit>0.1183</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as senofilcon A multifocal prod minus senofilcon A multifocal test.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Alternativie hypothesis is that senofilcon A multifocal prod is non-inferior to balafilcon A multifocal.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = -0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.2281</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.2243</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.6767</ci_lower_limit>
            <ci_upper_limit>0.2206</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as senofilcon A multifocal prod minus balafilcon A multifocal.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Senofilcon A Test</title>
        </group>
        <group group_id="E2">
          <title>Senofilcon A Prod</title>
        </group>
        <group group_id="E3">
          <title>Balafilcon A</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tom Karkkainen, OD</name_or_title>
      <organization>Vistakon</organization>
      <phone>904-443-3402</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

